Dong-A University Hospital is a major general hospital affiliated with Dong-A University in Busan, South Korea. The hospital is situated in the Seo-gu area of Busan, within 20 minutes of Dong-A University's Seunghak and Bumin campuses.

There are 992 beds in Dong-A University Hospital.

During the past decade, Dong-A University Hospital conducted 185 clinical trials. In the 10-year time frame, 185 clinical trials started and 59 clinical trials were completed, i.e. on average, 31.9% percent of trials that started reached the finish line to date. In the past 5 years, 71 clinical trials started and 47 clinical trials were completed. i.e. 66.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dong-A University Hospital" #1 sponsor was "Pfizer" with 15 trials, followed by "Hoffmann-La Roche" with 13 trials sponsored, "Chong Kun Dang Pharmaceutical" with 12 trials sponsored, "Dong-A University" with 12 trials sponsored and "Seung-Jung Park" with 12 trials sponsored. Other sponsors include 174 different institutions and companies that sponsored additional 109 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dong-A University Hospital" #1 collaborator was "CardioVascular Research Foundation, Korea" with 18 trials as a collaborator, "Eli Lilly and Company" with 8 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 5 trials as a collaborator, "Dong-A University Hospital" with 4 trials as a collaborator and "Coalition for Epidemic Preparedness Innovations" with 3 trials as a collaborator. Other collaborators include 115 different institutions and companies that were collaborators in the rest 101 trials.

According to Clinical.Site data, the most researched conditions in "Dong-A University Hospital" are "Coronary Artery Disease" (16 trials), "Alzheimer's Disease" (10 trials), "Gastric Cancer" (10 trials), "Ulcerative Colitis" (9 trials) and "Crohn Disease" (6 trials). Many other conditions were trialed in "Dong-A University Hospital" in a lesser frequency.

Most popular intervention types in "Dong-A University Hospital" are "Drug" (191 trials), "Other" (20 trials), "Biological" (17 trials), "Device" (16 trials) and "Procedure" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (49 trials), "Oxaliplatin" (7 trials), "Capecitabine" (5 trials), "Etrasimod" (4 trials) and "Etrolizumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Dong-A University Hospital" are 232 trials for "All" genders, 8 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Dong-A University Hospital". undefined are not yet recruiting, 47 are recruiting, 28 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 107 completed trials in Dong-A University Hospital, undefined suspended trials, and 30 terminated clinical trials to date.

Out of the total trials that were conducted in Dong-A University Hospital, 18 "Phase 1" clinical trials were conducted, 54 "Phase 2" clinical trials and 98 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 33 trials, and there were also 13 trials that are defined as “Not Applicable".